Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202605718359093Phase 1Not yet recruiting
Phase 1, randomised trial in postoperative pain comparing Bupivacaine wound infiltration with Ketorolac wound infiltration (2 arms). Primary endpoint: Mean pain scores using visual analogue scale. Planned start May 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202605718359093.